Upload
hoangdieu
View
217
Download
0
Embed Size (px)
Citation preview
2Strictly Confidential
Disclaimer
Any statements contained in this presentation that do not describe historical facts may constitute forward-looking
statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking
statements contained herein are based on current expectations, but are subject to risks and uncertainties that could
cause actual results to differ materially from those projected, including, but not limited to, risks and uncertainties relating
to adverse changes in conditions in the global economy and volatility in the capital markets, the integration of
businesses we have acquired or may acquire in the future, changing technologies, product development and market
acceptance of our products, the cost and pricing of our products, manufacturing, competition, dependence on
collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental
regulations, realization of anticipated benefits from economic stimulus programs, intellectual property rights, litigation,
and exposure to foreign currency fluctuations and other risk factors which shall be discussed from time to time in our
filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update these
forward-looking statements other than as required by law.
NO OFFER OR SOLICITATION; FURTHER INFORMATION
This presentation should be read together with “Management’s Discussion and Analysis of Financial Condition and
Results of Operations” and the consolidated financial statements and the related notes thereto included in the
preliminary prospectus. Investors are urged to read the applicable prospectus when it becomes available because it will
contain important information. We shall file a registration statement (including a prospectus) with the SEC for the
offering to which this presentation relates. Before you invest, you should read the prospectus in that registration
statement and other documents we have filed with the SEC for more complete information about and this offering. You
may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov
4Strictly Confidential
Extensive, fully integrated operations
Deep forestry seedling product portfolio
Comprehensive product development capabilities and proprietary technology
Strong brand recognition and distribution channels
Sophisticated sales and marketing programs
Experienced management team with strong track record
Business Highlights
5Strictly Confidential
Founded in 2000 through the consolidation of the
forestry R&D programs at Fletcher Challenge (now
Rubicon Limited), International Paper and Westvaco
Corporation (now MeadWestvaco)
Owns more than 7,200 acres and leases an
additional 400+ acres with over 200 employees
worldwide
Current products:
– Comprehensive radiata and loblolly pine
portfolios
– Hardwood seedlings
– Tropical eucalyptus seedlings for Brazil
– Tempered hardwood seedlings for the U.S.
– Eucalyptus biotechnology products under
development
Base of over 5,000 customers
Headquartered in Ridgeville, SC with operations in
Brazil and New Zealand
Generated $30 million in revenue and sold over 265
million seedlings in FY 2013
Company Highlights Founding Partners
Primary End Markets
Pulp & Paper Products Wood Products
Bioenergy Charcoal
ArborGen: Building a Global, High Growth Business by Bringing Proprietary Seedlings
that Offer “Step Changes” in Productivity to the Forestry Industry
ArborGen Snapshot
6Strictly Confidential
2007: MWV, Rubicon and IP contributed substantially all their commercial nurseries and orchards,
along with associated R&D programs
2012: Acquired the only global clonal pine competitor CellFor
Currently has over 100 years in aggregate of tree improvement research from industry leaders
Catalogued over 13,500 unique varieties for two largest commercial pine species
Licensed rights to produce and sell International Paper-eucalyptus germplasm in Brazil
Developed most broadly application-efficient eucalyptus transformation platform capability
ArborGen has Become a Global Leader in Forestry Genetics
Given the inherent time associated with tree improvement research and development,
ArborGen is decades ahead of any potential new market entrant
The Evolution of ArborGen
Federal Paper Board Co.
7Strictly Confidential
• ArborGen operates in three of the most attractive forestry markets in the world
• U.S., Brazil and ANZ (Australia & New Zealand combined) are ranked in the top six
countries in the world for roundwood production
Established Position in Key Markets
Source: 2012 production of industrial roundwood and most recent pricing available.
$995
$2,630 $3,169
$627
$2,675
$2,630 $1,435
$1,739
U.S. South China Brazil ANZ
Hardwoods Pine
Roundwood Production Value ($mm) Area of Planted Forests Worldwide (mm HA)
3
4
6
12
14
15
20
25
31
0 10 20 30 40
Eastern…
Oceania
Western…
Africa
Russia
Latin America
Rest of Asia
USA
China
ArborGen’s
current
operations
8Strictly Confidential
Germplasm
Repository
Includes 50
commercial tree
species and
hybrids
Provides genetic
material to
produce a wide
variety of
improved trees
Includes over
13,500 unique
varieties of
loblolly and
radiata alone
Tree
Improvement
Expertise
Expertise is built
on over 100
collective years of
tree improvement
research
Most
comprehensive
and extensive field
trial program in
forestry
Proprietary
Production
Process
Includes
proprietary
methods of
producing high-
quality products
on a large scale
Years of
experience allow
ArborGen to
maximize
production and
minimize
extraneous costs
Genomics
Focuses on the
application of
genetics and
molecular biology
to transform crop
and animal
production
ArborGen applies
genomics to trees,
accelerating the
production of
improved
variations on
existing MCP®
families
Biotechnology
Product
Development
Capabilities
Currently focused
on eucalyptus
Focused on
developing
eucalyptus
products with
improved growth
rates and yields,
herbicide and
insect resistance,
stress resistance
and improved
pulping efficiency
Leading Technology Platform
9Strictly Confidential
Increasing
Population
The world’s
population rose
12.7% between
2002 and 2012,
placing increasing
pressure on wood
products for
housing and other
necessities
Expansion of
Development
A rapid expansion
in development in
both modern and
developing
countries has led to
a surge in demand
for wood and paper
products
Expansion of
Conservation
Land
Over the past
decade, a
significant
percentage of the
remaining global
forests have been
set aside as
protected forests
Conversion to
Agricultural
Uses
A significant
amount of forestry
land has been
cleared to make
way for farming
Key Supply and Demand Dynamics
ArborGen is poised to take advantage of a significant market opportunity
10Strictly Confidential
“Ag-Forestry” Productivity Parallel
The productivity-improvement opportunity in Forestry is significant,
but it will require the use of advanced technologies
11Strictly Confidential
Market leader in U.S. and ANZ
Driving the markets to next-generation
seedlings
Housing recovery drives U.S. market size
New Products
Through
Technology
Pine somatic embryogenesis (varietals)
Genomics: Pine (ongoing) and eucalyptus (future)
Improved eucalyptus silviculture traits through biotechnology (herbicide
tolerance, insect resistance, drought tolerance)
Improved eucalyptus pulping economics through biotechnology
U.S. bioenergy
U.S. pulp and paper hardwoods
Brazil eucalyptus business launched
Brazil pine business launch in 2014
China a longer term opportunity
Geographic
Expansion
New End Uses
Transform
Established Core (U.S. and ANZ)
Multiple Opportunities to Drive Value
13Strictly Confidential
ArborGen’s U.S. Base Business is centered in the Southeastern U.S.
Key focus on loblolly pine and other pine species
Over 40 years of operations as the nation’s leading seedling supplier
− #1 market position
− Established distribution channels
− Well-known, annually-repeating customers
− Sales to 17 of the top 20 Southeastern U.S. forest landowners
− Core customer base includes Timber Investment Management Organizations
(TIMOs), corporate and private landowners
Deep pipeline of next-generation (non-transgenic) advanced products
Minimal technology and no regulatory risks
ArborGen is the only company in the U.S. market exclusively focused on
developing and providing superior genetics to the U.S. forestry industry
Base Business Overview
14Strictly Confidential
SuperTree Nursery
ArborGen Headquarters
Distribution Point
Sales Office
Orchards
North American Operations
16Strictly Confidential
Value of
ArborGen’s
higher-value
pine
genetics
Note: Data assumes last 5-yr average prices, silvilcutural regime and site dependent, bare-root products
$500
$700
$900
$1,100
$1,300
$1,500
$1,700
Base OP OP-A Op-S Op-E MCP-A MCP-S MCP-E Varietal-I
Bare Land Value (BLV) per Acre
Customer Breakeven $/Seedling $0.17 $0.26 $0.39 $0.69 $0.96 $1.18 $1.74
Average Selling Price $0.05 $0.06 $0.07 $0.12 $0.13 $0.18 $0.35
ArborGen has a range of higher value genetic products for introduction today
Each is set at a different price point, reflecting the value each creates for the customer
Pine Genetics Lead to EnhancedForest Value
17Strictly Confidential
Source: NC State University Industry Tree Improvement Program; Dr. Steve McKeand
0
10
20
30
40
50
60
70
80
'00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 '13 '14
Annual P
roduction
(mill
ions)
’01 – ‘14
CAGR
26%
80 million
U.S. Industry Controlled Pollination Growth
Growing Adoption of AdvancedGenetics in the U.S. Market
19Strictly Confidential
Brazil is the world’s largest hardwood pulp producer
− Productive capacity expected to grow significantly
as new projects are competed
− Annual eucalyptus plantings of approximately 800
million to 1 billion per year
Market is under-served as non-integrated growers have
no access to improved genetics
ArborGen’s products offer significant value to the
market
Entered the eucalyptus market in 2013
Entering pine market in 2014
Eucalyptus plantation near Caravelas, Brazil
0%
20%
40%
60%
80%
0.3
0
0.3
4
0.3
8
0.4
2
0.4
6
0.5
0
0.5
4
0.5
8
0.6
2
0.6
6
0.7
0
Clone 2
Clone 3Ma
rgin
al IR
R
R$/Seedling
Brazil Overview
20Strictly Confidential
Revolutionizing the Productivity of the Commercial Forestry Industry
Transition customers to higher-value products
Continued development of product portfolio
Expand into new high-growth geographies
Grow via expansion into emerging complementary end-markets
Leverage technology and business model to drive profits
Pursue strategic collaborations and acquisitions
Established ArborGen presence
Emerging ArborGen presence
Growth Strategy
21Strictly Confidential
Extensive, fully integrated operations
Deep forestry seedling product portfolio
Comprehensive product development capabilities and proprietary technology
Strong brand recognition and distribution channels
Sophisticated sales and marketing programs
Experienced management team with strong track record
Business Highlights